PETIA PAPAZOGLOU: Open Payments
NPI 1558798850 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 23 payments from 5 companies in 2025. Trend: 2023 $164 · 2024 $357 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $278 |
| Almatica Pharma LLC | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
Products named: VRAYLAR, LOREEV XR, REXULTI, CAPLYTA, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
